A randomized trial of radium-223 (Ra-223) dichloride and cabozantinib in patients (pts) with advanced renal cell carcinoma (RCC) with bone metastases (RADICAL/Alliance A031801) Meeting Abstract
| Authors: | McKay, R. R.; Jacene, H.; Atherton, P. J.; Burbano, G. P.; Ajmera, A.; Baghaie, S.; Koball, J.; Zemla, T. J.; Chen, R. C.; Choudhury, A. D.; Lang, J. M.; Cole, S.; Al Baghdadi, T.; Kwok, Y.; Beltran, H.; George, D. J.; Morris, M. J.; Choueiri, T. K. |
| Abstract Title: | A randomized trial of radium-223 (Ra-223) dichloride and cabozantinib in patients (pts) with advanced renal cell carcinoma (RCC) with bone metastases (RADICAL/Alliance A031801) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120306286 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.TPS4593 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS4593 -- Source: Wos |
